NDN and cancer: Of 351 cases, 146 cancers (41%) did not express necdin, scored as 0; 112 cancers (32%) had definite but low expression, scored as 1; 62 cancers (18%) had moderate expression, scored as 2; and 31 cancers (9%) had high expression, scored as 3 (Figure 1G).